Literature DB >> 11389056

Expression of nerve growth factor receptors and their prognostic value in human breast cancer.

S Descamps1, V Pawlowski, F Révillion, L Hornez, M Hebbar, B Boilly, H Hondermarck, J P Peyrat.   

Abstract

Nerve growth factor (NGF) has been shown recently to be mitogenic for human breast cancer cells. In the present study, we have assayed the expression of NGF receptors (NGFRs: TrkA and p75) mRNAs in 363 human primary breast cancers, using real-time quantitative reverse transcription-PCR. NGFRs were found in all of the tumor biopsies. TrkA and p75 were positively correlated and were respectively associated with the histoprognostic grading and the tumor type. NGFRs were both related to progesterone receptors. In univariate analyses, TrkA (>upper quartile) was associated with longer overall survival. Histoprognostic grading, tumor size, node involvement, and steroid receptors were also prognostic factors. In Cox multivariate analyses, TrkA was not a prognostic parameter. This study demonstrates the expression of NGFRs in breast cancer and points out that patients with high levels of TrkA have a more favorable overall survival prognosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11389056

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  36 in total

1.  TrkB inhibition by GNF-4256 slows growth and enhances chemotherapeutic efficacy in neuroblastoma xenografts.

Authors:  Jamie L Croucher; Radhika Iyer; Nanxin Li; Valentina Molteni; Jon Loren; W Perry Gordon; Tove Tuntland; Bo Liu; Garrett M Brodeur
Journal:  Cancer Chemother Pharmacol       Date:  2014-11-14       Impact factor: 3.333

Review 2.  Mechanism of cancer pain.

Authors:  Brian L Schmidt; Darryl T Hamamoto; Donald A Simone; George L Wilcox
Journal:  Mol Interv       Date:  2010-06

3.  AZ64 inhibits TrkB and enhances the efficacy of chemotherapy and local radiation in neuroblastoma xenografts.

Authors:  Radhika Iyer; Carly R Varela; Jane E Minturn; Ruth Ho; Anisha M Simpson; Jennifer E Light; Audrey E Evans; Huaqing Zhao; Kenneth Thress; Jeffrey L Brown; Garrett M Brodeur
Journal:  Cancer Chemother Pharmacol       Date:  2012-05-24       Impact factor: 3.333

4.  Nerve growth factor suppresses Ehrlich carcinoma growth.

Authors:  A V Osipov; T I Terpinskaya; V S Ulaschik; V I Tsetlin; Y N Utkin
Journal:  Dokl Biochem Biophys       Date:  2013-08-23       Impact factor: 0.788

Review 5.  Perineural growth in head and neck squamous cell carcinoma: a review.

Authors:  Joseph Roh; Thomas Muelleman; Ossama Tawfik; Sufi M Thomas
Journal:  Oral Oncol       Date:  2014-10-25       Impact factor: 5.337

Review 6.  Role of p75 neurotrophin receptor in stem cell biology: more than just a marker.

Authors:  Elisa Tomellini; Chann Lagadec; Renata Polakowska; Xuefen Le Bourhis
Journal:  Cell Mol Life Sci       Date:  2014-01-31       Impact factor: 9.261

7.  High-affinity neurotrophin receptors and ligands promote leukemogenesis.

Authors:  Zhixiong Li; Gernot Beutel; Mathias Rhein; Johann Meyer; Christian Koenecke; Thomas Neumann; Min Yang; Jürgen Krauter; Nils von Neuhoff; Michael Heuser; Helmut Diedrich; Gudrun Göhring; Ludwig Wilkens; Brigitte Schlegelberger; Arnold Ganser; Christopher Baum
Journal:  Blood       Date:  2008-12-04       Impact factor: 22.113

Review 8.  Oncogenes associated with drug resistance in ovarian cancer.

Authors:  Xia Liu; Yutao Gao; Yi Lu; Jian Zhang; Li Li; Fuqiang Yin
Journal:  J Cancer Res Clin Oncol       Date:  2014-07-06       Impact factor: 4.553

9.  Progesterone receptor A-regulated gene expression in mammary organoid cultures.

Authors:  Sarah J Santos; Mark D Aupperlee; Jianwei Xie; Srinivasan Durairaj; Richard Miksicek; Susan E Conrad; Jeffrey R Leipprandt; Ying S Tan; Richard C Schwartz; Sandra Z Haslam
Journal:  J Steroid Biochem Mol Biol       Date:  2009-04-19       Impact factor: 4.292

Review 10.  Functional proteomics of breast cancer for signal pathway profiling and target discovery.

Authors:  Hubert Hondermarck; Laurent Dollé; Ikram El Yazidi-Belkoura; Anne-Sophie Vercoutter-Edouart; Eric Adriaenssens; Jérôme Lemoine
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-10       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.